Whatever REDUCE-IT ultimately reveals (results from the completed study are expected in Q2 or Q3 2018), Salyer maintains Amarin has “a great story to tell, with or without the data.”
Tax Bill Is Good News for Life Sciences and Marketing
Although it’s a long way from the president’s desk, the Tax Cut and Jobs Act of 2017 contains plenty of good news for the life sciences industry and its marketing partners.
Infographic | HCPs must deal with communication breakdown
December 11, 2017
12:00 pm
Drugmakers are proud of the patient service programs they’ve developed. Yet there remains a disconnect in the way information is communicated to HCPs.
Experts weigh in: How will health technology advance in 2018?
December 6, 2017
12:00 pm
Innovation-minded executives share their thoughts and predictions for the year ahead.
How will the pharma industry fare in 2018 under Trump?
The most promising products in pharma’s pipeline will compete in a landscape that increasingly rewards big risks and places an emphasis on novel mechanisms. That comes with a catch.